GPnotebook and AMBOSS have made the same strategic move from opposite ends of medicine: each placed an AI interface over an established, curated medical knowledge library rather than over the open web. For a clinician choosing between them, the question is not which model is cleverer but whose library, and whose intended user, matches your working day.
The shared model
Both products follow the publisher-grounded pattern. A clinician asks a natural-language question; the system synthesises an answer from a bounded, internally curated corpus; citations point back into that corpus so the supporting material is inspectable. Both companies frame the AI as navigation and synthesis over trusted content, not as an autonomous adviser, and both are explicit that clinical judgement remains with the user.
The underlying content
GPnotebook's corpus is more than 35,000 concise, GP-authored primary-care articles built over three decades, supplemented where needed by authoritative sources such as NICE. AMBOSS's corpus is a structured, multi-specialty medical knowledge base with integrated drug information and selected external guidelines, developed by a large in-house clinician team. One library is shaped like UK general practice; the other is shaped like the whole of hospital medicine with a US and international orientation.
Target users
GPnotebook AI Answers is aimed squarely at UK GPs and primary-care professionals, and its example questions, drug switches, referral criteria, uncommon presentations, are the texture of a UK surgery. AMBOSS serves students, residents and practising clinicians across specialties, with its strongest footprint in the US and international markets, and AI Mode Clinical Care is pitched at physicians, nurse practitioners and physician associates at the point of care.
Clinical breadth and depth
For breadth within primary care, GPnotebook's long tail of concise GP-relevant topics is hard to match. For hospital and specialist depth, AMBOSS's structured coverage across specialties is the stronger asset, and it carries one differentiator GPnotebook currently lacks: an independent external evaluation, having ranked first among 31 systems in the Stanford-Harvard NOHARM benchmark for clinical care safety. UK users of AMBOSS must still supply the jurisdiction check, since its guideline layer is US-centred; UK users of GPnotebook get UK context natively but provenance that runs to summaries rather than national guidance directly.
The adjacent ecosystems
GPnotebook surrounds its answers with podcasts, videos, monthly quizzes, study groups and automatic CPD capture for Pro subscribers. AMBOSS surrounds its answers with a medical-school learning platform, question banks, a separate AI Mode Learning study copilot and developing EHR integration. Both understand that the answer engine is the front door to a wider product, which is why the comparison is really between ecosystems rather than chatbots.
The strategic similarity
Strip the branding away and both companies are executing the same thesis: the move from find an article to ask the library. It is the defining shift in medical publishing this decade, and the fact that it is happening simultaneously in UK primary care and international hospital medicine tells you it is structural rather than fashionable.
Where iatroX differs from both
iatroX is the AI-native rather than publisher-first version of the same category: instead of making one publisher's library conversational, it grounds retrieval directly in UK national guidance and medicines information, and combines that clinical search with adaptive examination preparation and a Socratic tutoring mode in one platform. For UK clinicians the practical effect is citations that land on NICE, CKS or the SmPC rather than on an intermediate summary, plus a learning system attached to the same engine.
Access, cost and how to evaluate both
Access models differ usefully. GPnotebook AI Answers can be trialled on a free account at 10 answers per month, with Pro at £7.99 monthly or £71.88 annually unlocking the 1,000-answer allowance and CPD capture. AMBOSS is subscription-based with trial options, and AI Mode Clinical Care rolled out initially to a limited group of users, so availability may depend on account type and region. Whichever you evaluate, use the same test set on both: one routine management question from your own week, one drug question, one referral threshold, and one question you already know the answer to in UK terms. The last is the discriminating test for a UK clinician, because it exposes jurisdiction drift immediately: an answer can be well sourced, well written and still be the correct answer to a different country's question.
Recommendations
For UK GPs wanting fast curated answers in familiar language, GPnotebook AI Answers is the natural publisher-grounded choice. For hospital doctors and trainees working across specialties, particularly with US or international exams and rotations in view, AMBOSS AI Mode Clinical Care is the stronger library. For international clinicians, AMBOSS's multi-market orientation gives it the edge. And for anyone whose daily questions are UK pathway questions, a UK-guideline-grounded engine belongs in the stack alongside whichever library you prefer.